UNSPSC 51343809: Dolutegravir/lamivudine/tenofovir DF

This classification denotes a combination drug for treatment of HIV. The first component, DOLUTEGRAVIR, has US FDA Unique Ingredient Identifier of DKO1W9H7M1. The second component, LAMIVUDINE, has US FDA Unique Ingredient Identifier of 2T8Q726O95. The third component, TENOFOVIR DISOPROXIL FUMARATE, has US FDA Unique Ingredient Identifier of OTT9J7900I.

UNSPSC 51343809 Dolutegravir/lamivudine/tenofovir DF is a Commodity code representing a single antiretroviral pharmaceutical product. Recent state and local solicitations under this code show minimal direct procurement activity for this specific drug formulation; the posted opportunities span diverse procurement categories with no clear alignment to antiretroviral medications, and the majority of recent records represent vendor networking events, informational forums, and unrelated health-service solicitations rather than procurement of this fixed-dose combination therapy.

The code appears inactive or underutilized in recent state and local government contracting. Of the sixteen opportunities posted since January 2026, none target dolutegravir/lamivudine/tenofovir DF specifically or reference HIV treatment pharmaceuticals. The Seminole County IFB (IFB60459723LAS, due July 26, 2023) sought naloxone and drug deactivation systems—opioid-response products unrelated to antiretroviral therapy. The City of Tucson Fire Department RFP (260305, due June 24, 2026) solicited emergency medical services pharmaceuticals and supplies with no mention of antiretroviral agents. The Pinellas County invitation to quote (260305ITQ, due April 23, 2026) procured forensic drug reference standards for toxicology analysis. The Minnesota Multistate Cooperative Purchasing Alliance RFP (S1070000015802, due March 26, 2026) targeted generic multi-source pharmaceuticals and OTC products through authorized wholesalers but did not specify antiretroviral formulations. The remaining posted opportunities—vendor forums, reverse trade shows, open houses, and departmental surveys from Williamson County, Marion County, Indian River County, Collin County, Richardson, Pasco County, and FAPPO—are business development and procurement education events without defined product procurement scopes. This code merits close monitoring for future solicitations, but current activity does not support active pursuit based on recent state and local opportunity volume.